Acorda Therapeutics to buy Parkinson's treatment developer

September 24, 2014 3:46 PM

7 0

Acorda Therapeutics to buy Parkinson's treatment developer

Ardsley drugmaker to pay $525 million for Civitas Therapeutics

NEW YORK – Acorda Therapeutics Inc. of Ardsley plans to buy privately held Civitas Therapeutics for $525 million in cash as the drugmaker seeks to expand into treatments for Parkinson's disease.

Also read: They helped get $23 million through stock fraud. Now, how many years will they get?

Read more

To category page

Loading...